<?xml version="1.0" encoding="UTF-8"?>
<oembed>
  <type>rich</type>
  <version>1.0</version>
  <title>How to Prescribe Off-Label With Henry Nasrallah, MD</title>
  <description>Joseph F. Goldberg, MD, in this installment of "Brain Trust: Conversations in Psychopharmacology," sits down with Henry Nasrallah, MD, to discuss off-label prescribing and polypharmacy.

Nasrallah bases the discussion off his landmark analysis that demonstrated 88% of DSM psychiatric diagnoses have no US Food and Drug Administration (FDA)-approved pharmacotherapy, leaving clinicians with no choice but to prescribe off-label for many of the patients they encounter. He argues that the FDA's diagnosis-centric approval framework, rather than a symptom- or circuit-based model, is a primary driver of this gap, noting that a shift toward symptom-level indications could render irrelevant much of current off-label practice.

Both clinicians emphasize that off-label prescribing, when rationale-based and neuroscientifically informed, constitutes responsible clinical care rather than reckless deviation. Nasrallah describes examples like using valproate for impulsive aggression in traumatic brain injury, clozapine augmentation for treatment-resistant suicidality, and high-dose modafinil for refractory depression—each grounded in mechanistic reasoning. Goldberg observes that "off-label practices are legitimate…good for patients and save a lot of lives," while cautioning that prescribers must understand what a drug does in the brain, not merely follow or ignore labeling.

The conversation also addresses the transdiagnostic model, polypharmacy, insurance barriers to off-label coverage, and the underutilization of clozapine. Nasrallah concludes by characterizing off-label discovery as "a creative process, the cutting edge of scientific advances," urging clinicians to publish case reports and share serendipitous findings to catalyze future trials.</description>
  <author-name>Brain Trust: Conversations in Psychopharmacology</author-name>
  <author-url>https://audioboom.com/channels/5169832-brain-trust-conversations-in-psychopharmacology</author-url>
  <provider-name>Audioboom</provider-name>
  <provider-url>https://audioboom.com</provider-url>
  <width type="integer">480</width>
  <height type="integer">95</height>
  <thumbnail-url>https://audioboom.com/i/43675319/600x600/c</thumbnail-url>
  <thumbnail-width type="integer">600</thumbnail-width>
  <thumbnail-height type="integer">600</thumbnail-height>
  <html>&lt;iframe width="100%" height="95" src="https://embeds.audioboom.com/posts/8911034/embed?v=202301" style="background-color: transparent; display: block; padding: 0; width: 100%" frameborder="0" allowtransparency="allowtransparency" scrolling="no" title="Audioboom player" allow="autoplay" sandbox="allow-downloads allow-forms allow-popups allow-same-origin allow-scripts allow-storage-access-by-user-activation allow-top-navigation-by-user-activation"&gt;&lt;/iframe&gt;</html>
</oembed>

